Our Team
Nitin Joshi, PhD
Chief Executive Officer
Nitin has 20+ years of experience in drug development and has actively contributed to various drug delivery products from new chemical entities to drug delivery applications. He has held senior positions at Elan, Alkermes, ALZA (J&J), and also served as the Co-Founder of Incline Therapeutics (acquired by The Medicines Company).
Srini Sripada
Chief Commercial Officer
Srini is classically trained marketing executive with 20+ years’ experience building iconic brands such as Campbell Soup, Advil analgesics, & Vaseline skin care at blue-chip marketing organizations (P&G, Unilever, Campbell Soup, Pfizer). Most recently Srini was at Pfizer where he took Advil to global share leadership, overseeing an integrated commercial and R&D organization. Srini is an alumnus of Columbia Business School.
Carmine J. Durham
Chief Strategy Officer
Carmine is an industry veteran with 30+ years experience in pharma and med tech operations. He has held senior positions at Knoll/BASF Pharma and Abbott Laboratories, and was formerly the VP of Corporate Development at BoneCare Int’l. which was subsequently sold to Genzyme (now Sanofi) for $660M. As a Co-Founder and former CEO of Zurex Pharma, Carmine has experience with start-ups, raised millions in equity and debt financings, and successfully executed several strategic transactions.
Marina Shevachman, PhD
Director, Product Development
Marina has 14+ years of experience in drug development, commercial manufacturing, and expanding product portfolio. She has a wide experience in drug product submission with a proven record of FDA approvals. She joined the CAGE Bio team in 2018. Prior to joining CAGE, she held senior-level scientist positions at Perrigo and Allergan.
Abhirup Mandal, PhD
Senior Research Scientist, Product Development
Abhirup joined the CAGE Bio team in 2020 after completing his postdoctoral training from Harvard University, which was primarily focused on understanding ionic liquid (IL)-based frameworks for delivering nucleic acids transdermally. He received his Ph.D. in Pharmaceutical Sciences from the University of Missouri, Kansas City.
Kevin Gelston, BS
Scientist
Kevin joined CAGE Bio in 2019 bringing 4+ years of formulation and transdermal research to the team. He has worked on various drug delivery technologies and holds transdermal drug delivery patents. Kevin received his B.S. in Chemistry from the University of California, Santa Barbara. Prior to joining CAGE, Kevin worked at Chrono Therapeutics.